Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.
Oura K, Morishita A, Tani J, Masaki T. · 2021
Read Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review. by Oura K, Morishita A, Tani J, Masaki T. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8198390.txt.
Introduction
Oura and co-authors review the immune setting of liver cancer and suppressive therapy for it. Hepatocellular carcinoma is the main form of liver cancer. It resists drugs and often returns after treatment.
New immune therapies have lengthened survival for some patients. A checkpoint inhibitor paired with a VEGF inhibitor now leads first-line care. How well these drugs work depends on the tumour immune setting. The review sums up that setting's parts and states. It aims to help doctors match patients to the right immune drugs. Resistance paths get close attention too.
Catalog record
| CREATOR | Oura K, Morishita A, Tani J, Masaki T. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 124 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |